
Benjamin Bleiberg, MD, explains how toxicity guides first-line care in EGFR-mutant NSCLC and previews ADCs in small cell lung cancer.

Benjamin Bleiberg, MD, explains how toxicity guides first-line care in EGFR-mutant NSCLC and previews ADCs in small cell lung cancer.

Drs Aredo and Bleiberg reflect on the experiences and relationships that shaped their transitions from fellowship into their first faculty positions in thoracic oncology.